§ Funding Round
Series B funding round for ArriVent Biopharma raising $160M in December 2022
Series B funding round for ArriVent Biopharma raising $160M in December 2022
| Investor | Firm Type | Partner |
|---|---|---|
Dimension Capital | — | — |
General Catalyst | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SR One | — | — |
| Organization | — | |
Westlake Village BioPartners | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$465M
Top Valuation
-
ArriVent Biopharma raised $160M in a Series B round.
The round was announced on 12/01/22.
